Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl

Ludwig Knabl, Tanmay Mitra, Janine Kimpel, Annika Rössler, André Volland, Andreas Walser, Hanno Ulmer, Lisa Pipperger, Sebastian C. Binder, Lydia Riepler, Katie Bates, Arnab Bandyopadhyay, Marta Schips, Mrinalini Ranjan, Barbara Falkensammer, Wegene Borena, Michael Meyer-Hermann, Dorothee von Laer
doi: https://doi.org/10.1101/2020.08.20.20178533
Ludwig Knabl
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanmay Mitra
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janine Kimpel
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annika Rössler
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Volland
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Walser
3Dr. Walser’s surgery, Ischgl, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanno Ulmer
4Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Pipperger
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian C. Binder
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydia Riepler
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie Bates
4Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnab Bandyopadhyay
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Schips
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mrinalini Ranjan
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
5Centre for Mind/Brain Sciences, University of Trento, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Falkensammer
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wegene Borena
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Meyer-Hermann
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
6Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmh@theoretical-biology.de dorothee.von-Laer@i-med.ac.at
Dorothee von Laer
1Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmh@theoretical-biology.de dorothee.von-Laer@i-med.ac.at
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe.

Methods Between April 21 and 27, a cross-sectional epidemiologic study targeting the full population of Ischgl (n = 1867), of which 79 % could be included (n = 1473, incl. 214 children), was performed. For each individual, the study involved a SARS-CoV-2 PCR, antibody testing and structured questionnaires. A mathematical model was used to help understand the influence of the determined seroprevalence on virus transmission.

Findings The seroprevalence was 42.4% (95% CI 39.8–44.7). Individuals under 18 showed a significantly lower seroprevalence of 27.1% (95% CI 21.3–33.6) than adults (45%; 95% CI 42.2–47.7; OR of 0.455, 95% CI 0.356–0.682, p< 0.001). Of the seropositive individuals, 83.7% had not been diagnosed to have had SARS-CoV-2 infection previously. The clinical course was generally mild. Over the previous two months, two COVID-19-related deaths had been recorded, corresponding to an infection fatality rate (IFR) of 0.25% (95% CI 0.03–0.91). Only 8 (0.5 %) individuals were newly diagnosed to be infected with SARS-CoV-2 during this study.

Interpretation Ischgl was hit early and hard by SARS-CoV-2 leading to a high local seroprevalence of 42.4%, which was lower in individuals below the age of 18 than in adults. Mathematical modeling suggests that a drastic decline of newly infected individuals in Ischgl by the end of April occured due to the dual impact from the non-pharmacological interventions (NPIs) and a significant immunization of the Ischgl population.

Funding Helmholtz Association, European Union’s Horizon 2020 research and innovation program, German Research Foundation (DFG), state Tyrol.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

TM was supported by the Helmholtz-Association, Zukunftsthema "Immunology and Inflammation" (ZT-0027). MMH has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003480 and the German Research Foundation (DFG) under Germany's Excellence Strategy EXC 2155 project number 390874280. The state Tyrol funded the testing materials used in the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical committee of the Medical University of Innsbruck

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Upon publication of our study, the data and codes will be available from the corresponding authors upon receipt of a suitable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl
Ludwig Knabl, Tanmay Mitra, Janine Kimpel, Annika Rössler, André Volland, Andreas Walser, Hanno Ulmer, Lisa Pipperger, Sebastian C. Binder, Lydia Riepler, Katie Bates, Arnab Bandyopadhyay, Marta Schips, Mrinalini Ranjan, Barbara Falkensammer, Wegene Borena, Michael Meyer-Hermann, Dorothee von Laer
medRxiv 2020.08.20.20178533; doi: https://doi.org/10.1101/2020.08.20.20178533
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl
Ludwig Knabl, Tanmay Mitra, Janine Kimpel, Annika Rössler, André Volland, Andreas Walser, Hanno Ulmer, Lisa Pipperger, Sebastian C. Binder, Lydia Riepler, Katie Bates, Arnab Bandyopadhyay, Marta Schips, Mrinalini Ranjan, Barbara Falkensammer, Wegene Borena, Michael Meyer-Hermann, Dorothee von Laer
medRxiv 2020.08.20.20178533; doi: https://doi.org/10.1101/2020.08.20.20178533

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8551)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1744)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10283)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1671)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (247)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1764)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)